ABBOTT
PRISM is the ultimate solution for the transfusion
market. It has revolutionized the industry due to
the following features and benefits:
As the most automated screening transfusion instrument
available, the ABBOTT PRISM instrument will
reduce the risk of accidents, errors or tampering
of results.
ABBOTT PRISM was specifically designed to improve
and automate cGMP monitoring and reporting throughout
the entire testing process.
ABBOTT PRISM reduces manual steps and operator
intervention up to 85 percent. ABBOTT PRISM
increases throughput by running up to 960 tests per
hour with STAT test capability in under one hour for
all available assays.
Abbott is the first to bring chemiluminescence technology
to the transfusion market with ABBOTT PRISM.
This technology offers improved assay performance
as well as speed and automation in one system.
Since 1996, countries have switched to ABBOTT PRISM
for impressive safety, quality, productivity and reliability.
There are over one hundred ABBOTT PRISM systems
Test of Record internationally.
ABBOTT
PRISM
Test Listing
